8.39% -0.5141

Aclarion Inc (ACON)

개요 뉴스 가격 이력 Financials 토론 예측

Relative Volume:

Aclarion Inc Stock (ACON) Company Profile

Aclarion Inc

Healthcare (1126)

833 275 2266

8181 ARISTA PLACE, BROOMFIELD

최신 SEC 제출 서류

ACON's Discussions on Twitter

ACON을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
ACON Aclarion Inc	5.9226	4.32M	49,300	-6.27M	-5.38M	-9.09
VEEV Veeva Systems Inc	220.53	36.70B	3.08B	860.33M	1.35B	5.1463
TEM Tempus Ai Inc	69.80	12.56B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	45.50	8.26B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	96.41	8.27B	1.15B	96.70M	-161.99M	1.09
BTSG Brightspring Health Services Inc	36.56	6.59B	11.99B	24.18M	234.31M	0.2956

Aclarion Inc 주식(ACON)의 최신 뉴스

Aclarion Inc (ACON) 재무 분석

Aclarion Inc (ACON)

Aclarion Inc Stock (ACON) Company Profile

ACON을(를) 다른 주식과 비교

Aclarion Inc 주식(ACON)의 최신 뉴스

Nasdaq Moves: Will ATLCP stock continue upward momentumWeekly Stock Summary & Daily Risk Controlled Trade Plans - moha.gov.vn

What drives Aclarion Inc stock priceReal Estate Investment Trusts & These 3 Stocks Could Change Your Portfolio - earlytimes.in

Aclarion shares move higher after Nociscan highlighted in spine surgery journal - MSN

Aclarion (ACON) Price Target Increased by 15.00% to 23.46 - Nasdaq

Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) - Orthopedics This Week

Can Aclarion Inc. Equity Warrant stock maintain growth trajectory2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser

Aclarion Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis

Will Aclarion Inc. stock deliver better than expected guidance2025 Performance Recap & AI Forecast Swing Trade Picks - Newser

Aclarion’s Nociscan featured in special pain issue of spine journal By Investing.com - Investing.com Nigeria

Is Aclarion Inc. (IT20) stock vulnerable to rate hikes2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser

How Aclarion Inc. (IT20) stock gains from tech spendingMarket Performance Recap & Weekly Stock Performance Updates - Newser

Why Aclarion Inc. (IT20) stock stays resilientJuly 2025 Decliners & Target Return Focused Picks - Newser

How sustainable is Aclarion Inc. Equity Warrant stock dividend payout2025 Market Trends & Detailed Earnings Play Alerts - Newser

Aclarion, Inc. Stock (ACON) Opinions on Nociscan Technology Publication - Quiver Quantitative

Aclarion stock rises after feature in special pain issue of spine journal By Investing.com - Investing.com South Africa

Aclarion stock rises after feature in special pain issue of spine journal - Investing.com Canada

Aclarion’s Nociscan featured in special pain issue of spine journal - Investing.com

Aclarion announces publication of Nociscan article in pain issue of IJSS - TipRanks

Aclarion's Nociscan Featured in International Journal of Spine Surgery's Special Pain Issue, Highlighting Advances in Chronic Low Back Pain Diagnosis - Quiver Quantitative

Aclarion (Nasdaq: ACON) Nociscan case study guides targeted spine surgery - Stock Titan

Can Aclarion Inc. (IT20) stock sustain double digit ROEJuly 2025 Rallies & AI Powered Buy and Sell Recommendations - Newser

Is Aclarion Inc. (IT20) stock suitable for passive index fundsJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - Newser

Will Aclarion Inc. (IT20) stock sustain uptrend momentumQuarterly Trade Report & Smart Swing Trading Techniques - Newser

Will Aclarion Inc. stock remain a Wall Street favoriteIPO Watch & Target Return Focused Stock Picks - Newser

Aug Intraday: Will QRAFT AI Enhanced U.S. Large Cap stock return to pre crash levelsJuly 2025 PostEarnings & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ

Will Aclarion Inc. Equity Warrant stock reach Wall Street targets2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser

How Aclarion Inc. stock performs in high volatility marketsTrade Exit Report & Advanced Swing Trade Entry Plans - Newser

Will Aclarion Inc. (IT20) stock outperform energy sector in 20252025 Volatility Report & AI Powered Market Trend Analysis - Newser

Aclarion, Inc. Appoints Jason Brosniak as Commercial Director for the Eastern U.S - marketscreener.com

Aclarion, Inc. (ACON) 15.7% in Intraday Trading: Appointment of Commercial Director Drives Interest - Stocks Telegraph

Aclarion appoints Jason Brosniak as commercial director, Eastern U.S. - TipRanks

Press Release: Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - 富途牛牛

Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - The Globe and Mail

Is Aclarion's Debt-Free Position The Backbone Of Its Next Phase Of Expansion? - RTTNews

2 innovative micro-cap stocks for 2026 - MSN

2 innovative micro-cap stocks for 2026 | 2025-12-01 | Investing News - Stockhouse

Is Aclarion Inc Equity Warrant a good long term investmentEarnings Forecast Updates & Affordable Growth Investments - earlytimes.in

Momentum Shift: Why Aclarion Inc. stock appeals to dividend seekersQuarterly Risk Review & Precise Buy Zone Identification - moha.gov.vn

Can Aclarion Inc. stock hit record highs againInflation Watch & Fast Moving Market Watchlists - moha.gov.vn

What margin trends mean for Aclarion Inc. stockMarket Activity Summary & Free Long-Term Investment Growth Plans - BỘ NỘI VỤ

Aclarion loss widens, but balance sheet remains strong - BizWest

Is Aclarion Inc a good long term investmentLarge Cap Stability Picks & Access Our Free Weekly Investment Letter - earlytimes.in

Critical Review: Aclarion (ACON) vs. The Competition - Defense World

Aclarion Inc. (ACON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Why Aclarion Inc. (IT20) stock stays on buy listsPortfolio Growth Summary & Smart Money Movement Tracker - newser.com

Is Aclarion Inc. Equity Warrant stock trading near support levels2025 Volatility Report & Daily Profit Maximizing Tips - newser.com

Positive Outlook on Aclarion, Inc. Driven by Revenue Growth and Strategic Investments - TipRanks

Ascendiant Capital Maintains Aclarion (ACON) Buy Recommendation - Nasdaq

Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga

Aclarion Inc (ACON) 재무 분석

매출

순이익

현금흐름

주당 순 이익

ACON과 유사한 종목